Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: A randomized, double-blind, placebo-controlled trial

European Neurology

Volumn 66, Issue 1, 2011, Pages 7-13

  Delbari, Ahmad ^a,b,c   Salman Roghani, Reza ^c   Lokk, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SABZEVAR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Cognition; Mood; Rehabilitation pharmacology; Stroke

Indexed keywords

LEVODOPA; METHYLPHENIDATE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOOD; MULTICENTER STUDY; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION;

AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEVODOPA; MALE; METHYLPHENIDATE; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PHYSICAL THERAPY MODALITIES; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959450881     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000329275     Document Type: Review

References (42)

1. Poynter B, Shuman M, Diaz-Granados N, Kapral M, Grace SL, Stewart DE: Sex differences in the prevalence of post-stroke depression: A systematic review. Psychosomatics 2009; 50: 563-569.
2. Provinciali L, Coccia M: Post-stroke and vascular depression: A critical review. Neurol Sci 2002; 22: 417-428. (Pubitemid 34436804)
3. Whyte EM, Mulsant BH: Post stroke depression: Epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002; 52: 253-264. (Pubitemid 35232092)
4. Gaete JM, Bogousslavsky J: Post-stroke depression. Expert Rev Neurother 2008; 8: 75-92.
5. Hackett ML, Anderson CS, House AO: Management of depression after stroke: A systematic review of pharmacological therapies. Stroke 2005; 36: 1092-1103.
6. Barry S, Dinan TG: Alpha-2 adrenergic receptor function in post-stroke depression. Psychol Med 2009; 20: 305-309.
7. Orr K, Taylor D: Psychostimulants in the treatment of depression: A review of the evidence. CNS Drugs 2007; 21: 239-257. (Pubitemid 46425629)
8. Leonard BE, McCartan D, White J, King DJ: Methylphenidate: A review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 2004; 19: 151-180. (Pubitemid 38514828)
9. Kline AE, Chen MJ, Tso-Olivas DY, Feeney DM: Methylphenidate treatment following ablation-induced hemiplegia in rat: Experience during drug action alters effects on recovery of function. Pharmacol Biochem Behav 1994; 48: 773-779. (Pubitemid 24217021)
10. Nutt JG, Fellman JH: Pharmacokinetics of levodopa. Clin Neuropharmacol 1984; 7: 35-50.
11. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B: Methylphenidate in early poststroke recovery: A double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998; 79: 1047-1050. (Pubitemid 28419310)
12. De Wit L, Kamsteegt H, Yadav B, Verheyden G, Feys H, De Weerdt W: Defining the content of individual physiotherapy and occupational therapy sessions for stroke patients in an inpatient rehabilitation setting. Development, validation and inter-rater reliability of a scoring list. Clin Rehabil 2007; 21: 450-459. (Pubitemid 47064939)
13. Gladstone DJ, Danells CJ, Armesto A, McIlroy WE, Staines WR, Graham SJ, Herrmann N, Szalai JP, Black SE, Subacute Therapy with Amphetamine and Rehabilitation for Stroke Study Investigators: Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: A randomized, double-blind, placebo-controlled trial. Stroke 2006; 37: 179-185. (Pubitemid 43732068)
14. Masand P, Pickett P, Murray GB: Psychostimulants for secondary depression in medical illness. Psychosomatics 1991; 32: 203-208.
15. Kempster PA, Frankel JP, Bovingdon M, Webster R, Lees AJ, Stern GM: Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989; 52: 718-723. (Pubitemid 19165636)
16. Lazarus LW, Winemiller DR, Lingam VR, Neyman I, Hartman C, Abassian M, Kartan U, Groves L, Fawcett: Efficacy and side effects of methylphenidate for poststroke depression. J Clin Psychiatry 1992; 53: 447-449. (Pubitemid 23018089)
17. Johnson G, Burvill PW, Anderson CS, Jamrozik K, Stewart-Wynne EG, Chakera TM: Screening instruments for depression and anxiety following stroke: Experience in the Perth community stroke study. Acta Psychiatr Scand 1995; 91: 252-257.
18. Agrell B, Dehlin O: Comparison of six depression rating scales in geriatric stroke patients. Stroke 1989; 20: 1190-1194. (Pubitemid 19226913)
19. Malakouti SK, Fatollahi P, Mirabzadeh A, Salavati M, Zandi T: Reliability, validity and factor structure of the GDS-15 in Iranian elderly. Int J Geriatr Psychiatry 2006; 21: 588-593. (Pubitemid 44043761)
20. Folstein MF, Folstein SE, McHugh PR: Minimental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
21. Foroughan M, Jafari Z, Shirinbayan P, Ghaemmagham Farahani Z, Rahgozar M: Validation of mini-mental state examination (MMSE) in the elderly people in Tehran. Advances in Cognitive Science 2008; 38: 29-33.
22. Lazarus LW, Moberg PJ, Langsley PR, Lingam VR: Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison. Arch Phys Med Rehabil 1994; 75: 403-406. (Pubitemid 24134116)
23. Popkin MK, Callies AL, Mackenzie TB: The outcome of antidepressant use in the medically ill. Arch Gen Psychiatry 1985; 42: 1160-1163. (Pubitemid 16191175)
24. Macleod AD: Methylphenidate in terminal depression. J Pain Symptom Manage 1998; 16: 193-198. (Pubitemid 28429068)
25. Ng KC, Chan KL, Straughan PT: A study of post-stroke depression in a rehabilitative center. Acta Psychiatr Scand 2007; 92: 75-79.
26. Williams LS, Ghose SS, Swindle RW: Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 2004; 161: 1090-1095. (Pubitemid 38735996)
27. Carod-Artal J, Egido JA, González JL, Varela de Seijas E: Quality of life among stroke survivors evaluated 1 year after stroke: Experience of a stroke unit. Stroke 2000; 31: 2995-3000.
28. Kimura M, Robinson RG, Kosier JT: Treatment of cognitive impairment after poststroke depression: A double-blind treatment trial. Stroke 2000; 31: 1482-1486. (Pubitemid 30437491)
29. Lokk J, Roghani RS, Delbari A: Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke -a randomized, double blind, placebo controlled trial. Acta Neurol Scand 2011; 123: 266-273.
30. Chemerinski E, Robinson RG, Kosier JT: Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001; 32: 113-117. (Pubitemid 32063833)
31. Masand P, Murray GB, Pickett P: Psychostimulants in post-stroke depression. J Neuropsychiatry Clin Neurosci 1991; 3: 23-27.
32. Massie MJ, Holland J:C Depression and the cancer patient. J Clin Psychiatry 1990; 51(7 suppl):12-19.
33. Woods SW, Tesar GE, Murray GB, Cassem NH: Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry 1986; 47: 12-15. (Pubitemid 16182752)
34. Johnson ML, Roberts MD, Ross AR, Witten CM: Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992; 71: 239-241.
35. Goodman L, Gilman A: Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, MacMillan Publishing Company, 1985.
36. Challman TD, Lipsky JJ: Methylphenidate: Its pharmacology and uses. Mayo Clin Proc 2000; 75: 711-721. (Pubitemid 30441501)
37. Robinson RG: The Clinical Neuropsychiatry of Stroke: Cognitive, Behavioral, and Emotional Disorders following Vascular Brain Injury. Cambridge, Cambridge University Press, 1998.
38. Zhou DH, Wang JY, Li J, Deng J, Gao C, Chen M: Frequency and risk factors of vascular cognitive impairment three months after ischemic stroke in China: The Chongqing stroke study. Neuroepidemiology 2005; 24: 87-95. (Pubitemid 39664113)
39. Grondin R, Zhang Z, Gerhardt GA, Gash DM: Dopaminergic therapy improves upper limb motor performance in aged rhesus monkeys. Ann Neurol 2000; 48: 250-253. (Pubitemid 30617045)
40. Cramer SC: Repairing the human brain after stroke. I. Mechanisms of spontaneous recovery. Ann Neurol 2008; 63: 272-287. (Pubitemid 351499857)
41. Seniów J, Litwin M, Litwin T, Lesniak M, Czlonkowska A: New approach to the rehabilitation of post-stroke focal cognitive syndrome: Effect of levodopa combined with speech and language therapy on functional recovery from aphasia. J Neurol Sci 2009; 283: 214-218.
42. Lee H, Kim SW, Kim JM, Shin IS, Yang SJ, Yoon JS: Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol 2005; 20: 97-104. (Pubitemid 40372485)